Macrogen Corp. krijgt accreditatie voor klinisch NGS-laboratorium
ROCKVILLE, Md.–(BUSINESS WIRE)– Macrogen Corp. (www.macrogenlab.com) maakt bekend dat zijn Clinical Lab voor NGS-services (NGS: Next Generation Sequencing) is geaccrediteerd door het Accreditation Committee van het College of American Pathologists (CAP). De accreditatie is gebaseerd op resultaten van een inspectie op locatie, die deel uitmaakt van het accreditatieprogramma van CAP.
“Macrogen toont leiderschap, innovatie en zet zich met passie in voor het behalen van excellente normen. Tegelijkertijd levert het bedrijf services van de hoogst mogelijke kwaliteit, uiteindelijk voor patiënten”, zei Bharati Jhaveri, medicus en voorzitter van de Raad voor Accreditatie van het CAP. “Het CAP feliciteert Macrogen Corp. met de CAP-accreditatie.
Deze bekendmaking is officieel geldend in de originele brontaal. Vertalingen zijn slechts als leeshulp bedoeld en moeten worden vergeleken met de tekst in de brontaal, die als enige rechtsgeldig is.
Contacts
Macrogen Corp.
Susan Chung, +1 301-251-1007
susanchung@macrogenlab.com
Macrogen Corp.’s Clinical NGS Laboratory Receives CAP Accreditation
ROCKVILLE, Md.–(BUSINESS WIRE)– Macrogen Corp. (www.macrogenlab.com) announces that its Clinical Lab that provides clinical NGS services has been awarded accreditation by the Accreditation Committee of the College of American Pathologists (CAP) based on results of a recent on-site inspection as part of the CAP’s Accreditation Programs.
“Macrogen demonstrates leadership, innovation, and a passionate commitment to standards of excellence while providing the highest quality services, ultimately for patients,” said Bharati Jhaveri, MD, FCAP, chair of the CAP’s Council on Accreditation. “The CAP congratulates Macrogen Corp. on its recent CAP Accreditation.”
The U.S. federal government recognizes the CAP Laboratory Accreditation Program, begun in the early 1960s, as being equal-to or more-stringent-than the government’s own inspection program.
During the CAP accreditation process, designed to ensure the highest standard of care for all laboratory patients, inspectors examine the laboratory’s records and quality control of procedures for the preceding two years. CAP inspectors also examine laboratory staff qualifications, equipment, facilities, safety program and record, and overall management.
The facility’s director, Carlos Ruiz, MD, FCAP, was advised of this national recognition and congratulated for the excellence of the services being provided.
“We are very proud at Macrogen Clinical Laboratory to be a CAP Accredited laboratory in Genomic Sequencing,” said Dr. Ruiz, “The future is exciting in finding ways to improve and enhance Clinical applications utilizing whole genome and whole exome sequencing.”
About Macrogen Corp.
Macrogen Corp. (Rockville, MD), established in 2005, also shares two decades of experience of Macrogen Inc. (KOSDAQ:038290) (Seoul, Korea) in top-quality genomic sequencing and analysis. Macrogen is continually expanding both globally and with the services that it provides, including the launching of CLIA-certified services in 2012. Macrogen adapts to the fast evolving genomics field by being the first to acquire new technologies and certifications. For more information, please visit http://www.macrogenlab.com
About the College of American Pathologists
As the world’s largest organization of board-certified pathologists and leading provider of laboratory accreditation and proficiency testing programs, the College of American Pathologists (CAP) serves patients, pathologists, and the public by fostering and advocating excellence in the practice of pathology and laboratory medicine worldwide. For more information, read the CAP Annual Report at cap.org.
View this news release online at:
http://www.businesswire.com/
Contacts
Macrogen Corp.
Susan Chung, +1 301-251-1007
susanchung@macrogenlab.com